Introduction

Sarah is a Research Associate in Health Economics. Her main research interests are economic evaluation, priority setting and preference elicitation. Her main areas of interest are in public health and outcomes valuation.

Qualifications

PhD in Public Health Economics, Newcastle University (2019)

MSc. Health Economics, University of York (2013)

BA (Hons) Politics, Philosophy and Economics, University of York (2011)

Previous Positions

Research placement, The Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA (2013)

Project Assistant, The York Health Economics Consortium, York (2012-2013) 

Projects

School for Public Health Equitable and Efficient Health systems (WP3)

PI: Professor Luke Vale

Can embedding the MapMe intervention, a tool to improve parental acknowledgement and understanding of childhood overweight and obesity, in the National Child Measurement Programme lead to improved long term child weight outcomes at one year? 

PI: Professor Ashley Adamson

PI: Dr Sarah Slight

Improving the diagnosis and management of neurodegenerative dementia of Lewy body type in the NHS (DIAMOND-Lewy)

PI: Professor John O'Brien

Supporting Excellence in End of Life Care for Dementia (SEED)

PI: Louise Robinson

Willingness of clinicians and patients to randomise into a study comparing ABlation with activer SURveillance in the management of incidentally diagnosed small renal tumours: a feasibility study (SURAB)

PI: Naeem Soomro

• Shen J, Hill S, Mott D, Breckons M, Vale L, Pickard R. Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations. PharmacoEconomics - Open 2019, 3(1), 5-20.
• Hill S, Oluboyedi Y, Becker F. Health Economics of Obesity. In: Weaver J, ed. Practical Guide to Obesity Medicine. St. Louis, Missouri: Elsevier, 2018, pp.9-15.
• Hill SR, Vale L, Hunter D, Henderson E, Oluboyedi Y. Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges. Health Policy 2017, 121(12), 1249-1262.
• Hill SR, Mason H, Poole M, Vale L, Robinson L. What is important at the end of life for people with dementia? The views of people with dementia and their carers. International Journal of Geriatric Psychiatry 2017, 32(9), 1037-1045.
• Brass D, Farr P, Reynolds N, Stocken D, Macdonald C, Wahie S, Weatherhead S, Wilkinson J, Lloyd J, Hill S, Fouweather T, Hampton P. An observer-blinded randomized controlled pilot study comparing localised psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of hand eczema. In: 95th Annual Meeting of the British Association of Dermatologists. 2015, Manchester, UK: Wiley-Blackwell.
• Strehle EM, Hill SR. Physicians' adherence to published guidelines regarding the outpatient care of pediatric patients with neurofibromatosis type 1. Gene Reports 2020, 20, 100697.